JP2018501266A5 - - Google Patents

Download PDF

Info

Publication number
JP2018501266A5
JP2018501266A5 JP2017533569A JP2017533569A JP2018501266A5 JP 2018501266 A5 JP2018501266 A5 JP 2018501266A5 JP 2017533569 A JP2017533569 A JP 2017533569A JP 2017533569 A JP2017533569 A JP 2017533569A JP 2018501266 A5 JP2018501266 A5 JP 2018501266A5
Authority
JP
Japan
Prior art keywords
group
carbon atoms
independently
optionally substituted
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018501266A (ja
JP6523461B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2015/050930 external-priority patent/WO2016102776A1/en
Publication of JP2018501266A publication Critical patent/JP2018501266A/ja
Publication of JP2018501266A5 publication Critical patent/JP2018501266A5/ja
Application granted granted Critical
Publication of JP6523461B2 publication Critical patent/JP6523461B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533569A 2014-12-23 2015-12-22 17β−HSD1−阻害剤のプロドラッグ Active JP6523461B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20146150 2014-12-23
FI20146150 2014-12-23
PCT/FI2015/050930 WO2016102776A1 (en) 2014-12-23 2015-12-22 Prodrugs of 17.beta.-hsd1 -inhibitors

Publications (3)

Publication Number Publication Date
JP2018501266A JP2018501266A (ja) 2018-01-18
JP2018501266A5 true JP2018501266A5 (enExample) 2019-01-17
JP6523461B2 JP6523461B2 (ja) 2019-06-05

Family

ID=55221442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017533569A Active JP6523461B2 (ja) 2014-12-23 2015-12-22 17β−HSD1−阻害剤のプロドラッグ

Country Status (5)

Country Link
US (1) US10413557B2 (enExample)
EP (1) EP3237431B1 (enExample)
JP (1) JP6523461B2 (enExample)
CN (1) CN107207561B (enExample)
WO (1) WO2016102776A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107207562B (zh) * 2014-12-23 2020-03-06 佛恩多制药有限公司 17β-HSD1抑制剂的前药
WO2018224736A2 (en) 2017-06-08 2018-12-13 Forendo Pharma Ltd Therapeutically active steroidal derivatives
US20250135007A1 (en) * 2021-12-20 2025-05-01 Ron Weiss Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof
WO2025185710A1 (zh) * 2024-03-08 2025-09-12 长春金赛药业有限责任公司 17β-HSD1抑制剂化合物、药物组合物及其应用
WO2026057048A1 (zh) * 2024-09-13 2026-03-19 长春金赛药业有限责任公司 17β-HSD1抑制剂、药物组合物及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2000125533A (ru) 1998-03-11 2002-10-20 Эндорешерш, Инк. (Ca) Ингибиторы 17-бета-гидроксистероиддегидрогеназ 5 и 3 типа и способы их применения
ATE355279T1 (de) 1998-08-07 2006-03-15 Novartis Vaccines & Diagnostic Pyrazole als modulatoren des östrogenrezeptors
GB9929302D0 (en) 1999-12-11 2000-02-02 Univ Cardiff Benzyl tetralins compositions and uses thereof
US6903102B2 (en) 2001-09-06 2005-06-07 Schering Corporation 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
PE20030705A1 (es) 2001-10-17 2003-08-21 Schering Corp Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes
US6750248B2 (en) 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
CA2506290C (en) 2002-11-18 2012-04-24 Schering Corporation 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AU2003293555A1 (en) 2002-12-17 2004-07-29 Schering Corporation 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2004085345A2 (en) 2003-03-21 2004-10-07 Yale University 15α-SUBSTITUTED ESTRADIOL CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS
GB0306718D0 (en) 2003-03-24 2003-04-30 Sterix Ltd Compound
US7465739B2 (en) 2003-06-10 2008-12-16 Solvay Pharmaceuticals B.V. Compounds and their use in therapy
US7754709B2 (en) 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
US8088758B2 (en) 2003-11-12 2012-01-03 Abbott Products Gmbh 17β-hydroxysteroid dehydrogenase type I inhibitors
TWI331154B (en) * 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
DE102004032674A1 (de) 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1
DE102004032673A1 (de) 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte D-Homo-estra-1,3,5(10)-triene als Inhibitoren der 17ß-Hydroxysteroiddehydrogenase Typ 1
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US8030298B2 (en) * 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
EP1888615B1 (en) * 2005-05-26 2012-05-16 Abbott Products GmbH 17 -hsd1 and sts inhibitors
JP5268917B2 (ja) 2006-09-19 2013-08-21 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 治療学的に有効なトリアゾール類及びそれらの使用
CA2671075A1 (en) * 2006-11-30 2008-06-05 Solvay Pharmaceuticals Gmbh Substituted estratrien derivatives as 17beta hsd inhibitors
MX2015017879A (es) * 2013-06-25 2017-03-01 Forendo Pharma Ltd Derivados de estratrientiazol 17-nitrogeno substitutidos terapeuticamente activos como inhibidores de 17.beta-hidroxiestero ide deshidrogenasa.
CN105518017B (zh) 2013-06-25 2020-07-14 佛恩多制药有限公司 治疗活性的作为1型17β-羟基类固醇脱氢酶抑制剂的雌三烯噻唑衍生物
AR096728A1 (es) 2013-06-25 2016-01-27 Forendo Pharma Ltd Derivados de estratrieno-tiazol terapéuticamente activos
CN107207562B (zh) * 2014-12-23 2020-03-06 佛恩多制药有限公司 17β-HSD1抑制剂的前药

Similar Documents

Publication Publication Date Title
EA201170096A1 (ru) Замещенные производные пиримидона
RU2020110780A (ru) Ингибитор fgfr и его медицинское применение
JP2016506958A5 (enExample)
JP2017521436A5 (enExample)
JP2017511357A5 (enExample)
JP2019104748A5 (enExample)
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
MX2014015501A (es) Carboxamidas heterociclicas fungicidas.
AR058554A1 (es) Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
PH12016502154A1 (en) Pyridazonine herbicides
JP2016505614A5 (enExample)
JP2016536364A5 (enExample)
TR201909694T4 (tr) Janus kinaz (jak) inhibitörleri.
EA201591429A1 (ru) 2,3-дизамещенные производные 1-ацил-4-амино-1,2,3,4-тетрагидрохинолинов и их применение в качестве ингибиторов бромодомена
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
EA201591703A1 (ru) Замещенные 2-азабициклы и их применение в качестве модуляторов рецепторов орексина
PH12012501773A1 (en) Arylethynyl derivatives
JP2014526533A5 (enExample)
UA117151C2 (uk) N-ациліміногетероциклічні сполуки
RU2021109549A (ru) ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
JP2008505194A5 (enExample)
JP2014510147A5 (enExample)
JP2015530408A5 (enExample)
JP2015063518A5 (ja) 有機化合物
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии